[Radiofrequency ablation for Barret's esophagus].
Barrett's esophagus consists of the replacement of normal squamous epithelium by a specialised columnar lined epithelium referred to as intestinal metaplasia in the esophagus. It represents a premalignant lesion. The prevalence of Barrett's esophagus is around 1.6%. Esophageal adenocarcinoma results from the development of dysplasia progressing from low to high grade dysplasia and finally adenocarcinoma. Radiofrequency ablation currently represents the treatment of choice in eradicating Barrett's esophagus with associated dysplasia. The technique is based on the application of a radiofrequency current that enables the destruction of the superficial modified epithelium. This new approach presents a good security profile and, compared to other ablative techniques, shows superior results regarding Barrett's eradication.
Service de gastroentérologie et d'hépatologie, CHUV et Université de Lausanne, 1011 Lausanne. montserrat.fraga@chuv.ch
M
M
Fraga
C
C
Doerig
G
G
Dorta
C
C
Nichita
D000230:Adenocarcinoma / Q000209:etiology / Q000517:prevention & control*; D001471:Barrett Esophagus / Q000473:pathology / Q000628:therapy*; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods*; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control*; D006801:Humans